1. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet. 2016;388(10049):1081–8.
2. World Health Organization. Hepatitis C, Fact sheet 2017 [Available from:
http://www.who.int/mediacentre/factsheets/fs164/en
/ (Access 16 February 2018).
3. Umar M, Akhter TS. New direct acting antiviral agents for the treatment of hepatitis C: 2016 and beyond. J Coll Physicians Surg Pak. 2016;26(10):843–50.
4. Lynch SM, Wu GY. Hepatitis C virus: a review of treatment guidelines, cost-effectiveness, and access to therapy. J Clin Transl Hepatol. 2016;4(4):310–9.
5. Wong JB. Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies. PharmacoEconomics. 2006;24(7):661–72.